Updated October 10, 2026

Independent · Owner-operatedSubscribe

REGULATORYSerina Therapeutics removes Series A preferred stock designationREGULATORYVolato Group signs $1 billion equity line of credit with DFU, LLCREGULATORYQuantum Cyber N.V. Launches $100 Million At-The-Market OfferingREGULATORYArtelo Biosciences flags uncertainty over Nasdaq $5M market value ruleREGULATORYAgEagle Aerial Systems COO Brent Pope to Retire in NovemberREGULATORYInvesco Reports Preliminary September AUM at $2.54 TrillionREGULATORYSerina Therapeutics removes Series A preferred stock designationREGULATORYVolato Group signs $1 billion equity line of credit with DFU, LLCREGULATORYQuantum Cyber N.V. Launches $100 Million At-The-Market OfferingREGULATORYArtelo Biosciences flags uncertainty over Nasdaq $5M market value ruleREGULATORYAgEagle Aerial Systems COO Brent Pope to Retire in NovemberREGULATORYInvesco Reports Preliminary September AUM at $2.54 Trillion

Front Page/News/Regulatory

RegulatoryOctober 10, 2026

Serina Therapeutics removes Series A preferred stock designation

Serina Therapeutics, Inc. filed a Certificate of Elimination with the Delaware Secretary of State on October 5, 2026, removing the specific designation for its Series A Convertible Preferred Stock. The move formally…

ByEmmett Donovan

Read2 min

TickersSER

Filed by NewsNovo

Source

sec.gov

Disclosure

Editorial. NewsNovo is independent. Nothing in this article is investment advice; treat figures and quotations as starting points for your own research.

← Back to all news

Related coverage

Serina Therapeutics removes Series A preferred stock designation

Read next

Invesco Reports Preliminary September AUM at $2.54 Trillion

Kayne Anderson BDC sets November 5 date for Q3 2026 earnings release

Citizens, Inc. Signs Bestow Agreement for Insurance Platform